Long-term survival and spontaneous tumour regression in stage IV melanoma: Possible role of adrenalectomy and massive tumour antigen release;Survie prolongée et régression tumorale spontanée au cours d'un mélanome de stade IV: rôles possibles de la surrénalectomie et de la libération massive d'antignes tumoraux

Annales de Dermatologie et de Venereologie

Volumn 137, Issue 6-7, 2010, Pages 464-467

  Wantz, M ^a   Antonicelli, F ^b   Derancourt, C ^c   Bernard, P ^a   Avril, M F ^d   Grange, F ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b CNRS   (France)

^c CHRU de Fort de France   (France)

^d Université Paris 5 ^*  (France)

Author keywords

Adrenalectomy; Autoimmunity; Long term survival; Melanoma; Tumour regression

Indexed keywords

TUMOR ANTIGEN;

ADRENALECTOMY; ADULT; ARTICLE; AUTOIMMUNITY; CANCER STAGING; CASE REPORT; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG METASTASIS; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SURVIVAL TIME; TUMOR REGRESSION;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; AMPUTATION; ANTIBODIES, ANTICARDIOLIPIN; FEMALE; FINGERS; HUMANS; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 77954085820     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2010.04.009     Document Type: Article

References (17)

1. S.S. Legha Durable complete response in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy Semin Oncol 24 1997 S39 43
2. L.M. Samuel, V.J. Harvey, P.L. Mitchell, P.I. Thompson, D. Mak, and P. Melville Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma Eur J Cancer 30 1994 2054 2056
3. K.A. Margolin, J.H. Doroshow, S.A. Akman, L.A. Leong, R.J. Morgan, and G. Somlo Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma J Clin Oncol 10 1992 1574 1578
4. D. Berd, and M.J. Mastrangelo Combination chemotherapy of metastatic melanoma J Clin Oncol 13 1995 796 797
5. E.M. Kokoschka, J. Klocker, U. Loicht, A. Rehberger, W. Macheiner, and M. Micksche Interferon-alpha-carboplatin combination for metastatic melanoma: phase II study Eur J Cancer 30A 14 1994 2182 2183
6. C.M. Balch, S.J. Soog, T.M. Murad, J.W. Smith, W.A. Maddox, and J.R. Durant A multifactorial analysis of melanoma IV Prognostic factors in 200 melanoma patients with distant metastases (stage III) J Clin Oncol 1 1983 126 134
7. T. Tchen, F. Léonard, C. Derancourt, G. Perceau, C. Goutorbe, and Z. Reguiai Long-term survivors in stage IV melanoma: a regional population-based study in France Eur J Dermatol 19 2009 38 43
8. I. Satzger, F. Schenck, A. Kapp, and R. Gutzmer Spontaneous regression of melanoma with distant metastases-report of a patient with brain metastases Eur J Dermatol 16 2006 454 455
9. H. Gogas, J. Ioannovich, U. Dafni, C. Stavropoulou-Gioks, K. Frangia, and D. Tsoutsos Prognostic significance of auto-immunity during treatment of melanoma with interferon New Engl J Med 354 2006 709 718
10. S. Vercambre-Darras, I. Fajardy, F. Piette, and L. Mortier Does spontaneous autoimmunity improve survival in visceral metastatic melanoma? Br J Dermatol 157 2007 413 415
11. P.I. Haigh, R. Essner, J.C. Wardlaw, S.L. Stern, and D.L. Morton Long-term survival after complete resection of melanoma metastatic to the adrenal gland Ann Surg Oncol 6 1999 633 639
12. E.A. Mittendorf, S.J. Lim, C.W. Schacherer, A. Lucci, J.N. Cormier, and P.F. Mansfield Melanoma adrenal metastasis: natural history and surgical management Am J Surg 195 2008 363 368
13. F.J. Collinson, T.K. Lam, W.M. Bruijn, J.H. de Wilt, M. Lamont, and J.F. Thompson Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy Ann Surg Oncol 5 2008 1741 1749
14. A. Mackensen, G. Carcelain, S. Viel, M.C. Raynal, H. Michalaki, and F. Triebel Direct evidence to support the immunosurveillance concept in a human regressive melanoma J Clin Invest 93 1994 1397 1402
15. F. Benchetrit, A. Gazagne, O. Adotevi, N. Haicheur, B. Godard, and C. Badoual Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy Bull Cancer 90 2003 677 685
16. D.G. DeNardo, M. Johansson, and L.M. Coussens Immune cells as mediators of solid tumor metastasis Cancer Metastasis Rev 27 2008 11 18
17. E.A. Reits, J.W. Hodge, C.A. Herberts, T.A. Groothuis, M. Chakraborty, and E.K. Wansley Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy J Exp Med 203 2006 1259 1271 (Pubitemid 43736595)